Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.390
+0.170 (4.03%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $564.34 million as of March 9, 2026. Its market cap has decreased by -15.75% in one year.
Market Cap
564.34M
Enterprise Value
325.26M
1-Year Change
-15.75%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $564.34M, a decrease of -75.04%. That is a compound annual growth rate of -25.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 542.48M | -15.99% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tactile Systems Technology | 646.47M |
| Avanos Medical | 618.03M |
| SI-BONE | 610.81M |
| Perspective Therapeutics | 566.15M |
| Bioventus | 563.27M |
| BrainsWay | 510.81M |
| Orthofix Medical | 506.62M |
| Varex Imaging | 483.33M |